We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Among adults with pulmonary arterial hypertension, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A previous study found that seralutinib lowered ...

In adults with Fontan circulation, a higher pulmonary vascular resistance index (PVRI) during exercise and failure to reduce the PVRI were associated with a greater risk for death or heart ...

WASHINGTON -- The novel investigational therapy seralutinib effectively reduced pulmonary vascular resistance (PVR) in patients with pulmonary arterial hypertension (PAH) on standard background ...

Increased pulmonary vascular resistance independently predicts acute exacerbation-related hospitalization in patients with COPD-PH.

Drugs currently marketed for pulmonary arterial hypertension have been able to extend the lives of patients but have shown limitations in their ability to prevent or reverse the disease. A novel ...